Patent Assignment
Reel/Frame 045947/0752
Change of Name
Recorded: 2018-03-29
Pages: 65
Assignor
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Executed: 2011-07-01
Assignee
BAYER PHARMA AKTIENGESELLSCHAFT
MUELLERSTRASSE 178, BERLIN, 13353, GERMANY
Covered Property
(1)
Substituted 2,3-Dihydroimidazo[1,2-C]Quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis
Patent:
46,856 →
Application:
15/398,916 →
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 29, 2018
From: HENTENMANN, MARTIN; WOOD, JILL; SCOTT, WILLIAM; MICHELS, MARTIN
To: BAYER PHARMACEUTICALS CORPORATION
Reel/Frame 045386/0135 →
Assignment of Assignor's Interest
Mar 29, 2018
From: BAYER PHARMACEUTICALS CORPORATION
To: BAYER HEALTHCARE AG
Reel/Frame 045386/0509 →
Nunc Pro Tunc Assignment
Mar 29, 2018
From: BAYER PHARMACEUTICALS CORPORATION
To: BAYER HEALTHCARE AG
Reel/Frame 045387/0403 →
Assignment of Assignor's Interest
Mar 29, 2018
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 045388/0263 →
Merger
Mar 29, 2018
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 045947/0609 →
Change of Address
Jun 12, 2023
From: BAYER INTELLECTUAL PROPERTY GMBH
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 064021/0344 →